Skip to main content

Table 1 Sample characteristics and prevalence ratio for somatization

From: Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care

Characteristics

Somatizers (n = 57)

Non somatizers (n = 110)

All (n = 167)

Prevalence ratio

95% CI

Gender

     

   Women

82.5

70.0

74.3

1.63

0.91-2.93

   Men

17.5

30.0

25.7

  

Age (years)

44.0 (12.4)

43.6 (16.0)

43.7 (14.9)

  

   <45

47.4

53.6

51.5

  

   ≥45

52.6

46.4

48.5

1.18

0.77-1.80

Marital status

     

   Single

14.0

21.8

19.2

  

   Married

70.2

62.7

65.3

1.47

0.77-2.81

   Divorced

14.0

10.9

12.0

1.60

0.72-3.58

   Widowed

1.8

4.5

3.6

0.67

0.10-4.40

Years of full time education

     

   <4

5.3

9.1

7.8

0.90

0.30-2.75

   4-8

33.3

22.7

26.3

1.69

0.92-3.11

   9-12

42.1

39.1

40.1

1.40

0.77-2.56

   >12

19.3

29.1

25.7

  

Occupational status

     

   Employed

66.7

57.3

60.5

  

   Unemployed

17.5

14.5

15.6

1.02

0.59-1.77

   Retired

14.0

19.1

17.4

0.73

0.39-1.39

   Others

1.8

9.1

6.6

0.24

0.04-1.59

Household composition

     

   Single

5.3

8.2

7.2

  

   Couple

14.0

23.6

20.4

0.94

0.30-2.98

   Couple with sons/parents

70.2

58.2

62.3

1.54

0.56-4.22

   Others

10.5

10.0

10.2

1.41

0.44-4.56

Income (minimum wage)

     

   <1

8.9

10.2

9.8

1.06

0.43-2.60

   1-3

73.2

67.6

69.5

1.22

0.69-2.17

   >3

17.9

22.2

20.7

  

Comorbidity

     

   Depression (current)

38.6

12.7

21.6

2.28

1.56-3.36

   Anxiety (current)

38.6

15.5

23.4

2.06

1.39-3.06

   Any current depression/anxiety

57.9

21.8

34.1

2.65

1.75-4.03

   Personality disorder

24.6

9.1

14.4

1.94

1.27-2.95

   Hypochondria

6.0

3.0

4.0

1.53

0.67-3.53

   Medicated psychoses

1.8

1.8

1.8

  

SOMS-2

     

   No of symptoms§

     

women

5 [2-7]

1 [0-3]

2 [0-4]

  

men

2 [0-11]

0 [0-2]

1 [0-3]

  

   Wellbeing affected

83.0

50.0

64.8

2.65

1.39-5.06

   ADL affected

72.3

48.3

59.0

1.81

1.09-3.01

  1. Prevalence ratio: prevalence in category indicated against category with no values shown; CI: confidence interval; mean (standard deviation); for 164 participants; §median [1st and 3rd quartiles]; for those reporting symptoms (n = 105) and prevalence ratio for (yes vs. no)